Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?

Tytuł:
Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?
Autorzy:
Mulero, P.
Córdova, C.
Hernández, M.
Martín, R.
Gutiérrez, B.
Muñoz, J. C.
Redondo, N.
Gallardo, I.
Téllez, N.
Nieto, M. L.
Temat:
MULTIPLE sclerosis
NETRINS
BIOMARKERS
ENCEPHALOMYELITIS
INFLAMMATION
TUMOR necrosis factors
PROGNOSIS
Źródło:
European Journal of Neurology; Sep2017, Vol. 24 Issue 9, p1108-1115, 8p, 2 Charts, 4 Graphs
Czasopismo naukowe
Background and purpose Netrin-1, an axon guidance protein, reduces serum levels of pro-inflammatory mediators and stabilizes the blood−brain barrier limiting the entrance of immune cells into the central nervous system. The aim was to investigate its presence in the experimental autoimmune encephalomyelitis ( EAE) model and in multiple sclerosis ( MS) patients with and without clinical activity. Methods Netrin-1 levels were evaluated in EAE mouse tissues. Afterwards, serum netrin-1 was cross-sectionally quantified in 90 patients with different MS phenotypes and 30 control subjects. An additional group of 10 relapsing−remitting MS ( RRMS) patients was longitudinally evaluated throughout a relapse ( RRMSr) with an interval of 60 days. Tumour necrosis factor α ( TNFα), a reference inflammatory cytokine, and netrin-1 were quantified by enzyme-linked immunosorbent assay. Results Experimental autoimmune encephalomyelitis mice showed significantly lower netrin-1 levels and higher TNFα amounts in sera, spinal cord and cerebella than healthy control mice. MS patients showed significantly lower serum netrin-1 levels than controls (511.62 ± 209.30 and 748.32 ± 103.24 pg/ml, respectively; P ≤ 0.005). The lowest protein levels were found in RRMSr, remaining significantly lower throughout the relapse. TNFα serum concentrations were higher in MS patients compared to controls, and negatively correlated with netrin-1 levels ( r = −0.3734, P ≤ 0.0001). Conclusions Netrin-1 decreased in EAE and in MS patients, mainly during relapse, suggesting an anti-inflammatory role of netrin-1. Further research should be performed in a larger cohort of patients to validate netrin-1 as a biomarker of MS inflammatory activity. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies